Isotschimgin is primarily used in research settings for its bioactive properties, particularly in the study of cellular signaling pathways. It has shown potential as an inhibitor in specific enzyme systems, making it valuable in the development of targeted therapies for inflammatory conditions and certain types of cancer. Due to its structural characteristics, it is also employed in the synthesis of more complex pharmacologically active compounds. Its application extends to in vitro assays where modulation of protein activity is required, aiding in the understanding of disease mechanisms and drug response at the molecular level.